vs
HEARTLAND EXPRESS INC（HTLD）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
ROGERS CORP的季度营收约是HEARTLAND EXPRESS INC的1.1倍（$200.5M vs $179.4M），ROGERS CORP净利率更高（2.2% vs -10.8%，领先13.1%），ROGERS CORP同比增速更快（5.2% vs -26.1%），ROGERS CORP自由现金流更多（$1.1M vs $-44.2M），过去两年ROGERS CORP的营收复合增速更高（-3.3% vs -18.5%）
哈特兰德快运是一家总部位于艾奥瓦州北利伯蒂的美国公路货运企业，核心业务为覆盖美国全境的整车公路运输服务，在北美干线货运领域拥有稳定的运营网络与行业经验。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
HTLD vs ROG — 直观对比
营收规模更大
ROG
是对方的1.1倍
$179.4M
营收增速更快
ROG
高出31.3%
-26.1%
净利率更高
ROG
高出13.1%
-10.8%
自由现金流更多
ROG
多$45.3M
$-44.2M
两年增速更快
ROG
近两年复合增速
-18.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $179.4M | $200.5M |
| 净利润 | $-19.4M | $4.5M |
| 毛利率 | — | 32.2% |
| 营业利润率 | -12.7% | — |
| 净利率 | -10.8% | 2.2% |
| 营收同比 | -26.1% | 5.2% |
| 净利润同比 | -949.2% | 421.4% |
| 每股收益（稀释后） | $-0.24 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HTLDROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $179.4M | $201.5M | ||
| Q3 25 | $196.5M | $216.0M | ||
| Q2 25 | $210.4M | $202.8M | ||
| Q1 25 | $219.4M | $190.5M | ||
| Q4 24 | $242.6M | $192.2M | ||
| Q3 24 | $259.9M | $210.3M | ||
| Q2 24 | $274.8M | $214.2M |
净利润HTLDROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-19.4M | $4.6M | ||
| Q3 25 | $-8.3M | $8.6M | ||
| Q2 25 | $-10.9M | $-73.6M | ||
| Q1 25 | $-13.9M | $-1.4M | ||
| Q4 24 | $-1.9M | $-500.0K | ||
| Q3 24 | $-9.3M | $10.7M | ||
| Q2 24 | $-3.5M | $8.1M |
毛利率HTLDROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 31.6% | ||
| Q1 25 | — | 29.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | — | 35.2% | ||
| Q2 24 | — | 34.1% |
营业利润率HTLDROG
| Q1 26 | — | — | ||
| Q4 25 | -12.7% | 3.5% | ||
| Q3 25 | -3.7% | 7.3% | ||
| Q2 25 | -5.9% | -33.3% | ||
| Q1 25 | -6.8% | -0.2% | ||
| Q4 24 | 0.4% | -6.6% | ||
| Q3 24 | -2.7% | 6.9% | ||
| Q2 24 | 0.1% | 5.3% |
净利率HTLDROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | -10.8% | 2.3% | ||
| Q3 25 | -4.2% | 4.0% | ||
| Q2 25 | -5.2% | -36.3% | ||
| Q1 25 | -6.3% | -0.7% | ||
| Q4 24 | -0.8% | -0.3% | ||
| Q3 24 | -3.6% | 5.1% | ||
| Q2 24 | -1.3% | 3.8% |
每股收益（稀释后）HTLDROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-0.24 | $0.20 | ||
| Q3 25 | $-0.11 | $0.48 | ||
| Q2 25 | $-0.14 | $-4.00 | ||
| Q1 25 | $-0.18 | $-0.08 | ||
| Q4 24 | $-0.03 | $-0.04 | ||
| Q3 24 | $-0.12 | $0.58 | ||
| Q2 24 | $-0.04 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.5M | $195.8M |
| 总债务越低越好 | $154.1M | — |
| 股东权益账面价值 | $755.3M | $1.2B |
| 总资产 | $1.2B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.20× | — |
8季度趋势，按日历期对齐
现金及短期投资HTLDROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $18.5M | $197.0M | ||
| Q3 25 | $32.7M | $167.8M | ||
| Q2 25 | $22.9M | $157.2M | ||
| Q1 25 | $23.9M | $175.6M | ||
| Q4 24 | $12.8M | $159.8M | ||
| Q3 24 | $30.7M | $146.4M | ||
| Q2 24 | $23.9M | $119.9M |
总债务HTLDROG
| Q1 26 | — | — | ||
| Q4 25 | $154.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $187.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益HTLDROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $755.3M | $1.2B | ||
| Q3 25 | $775.6M | $1.2B | ||
| Q2 25 | $786.7M | $1.2B | ||
| Q1 25 | $807.7M | $1.3B | ||
| Q4 24 | $822.6M | $1.3B | ||
| Q3 24 | $825.7M | $1.3B | ||
| Q2 24 | $836.8M | $1.3B |
总资产HTLDROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.3B | $1.5B | ||
| Q1 25 | $1.3B | $1.5B | ||
| Q4 24 | $1.3B | $1.5B | ||
| Q3 24 | $1.4B | $1.5B | ||
| Q2 24 | $1.4B | $1.5B |
负债/权益比HTLDROG
| Q1 26 | — | — | ||
| Q4 25 | 0.20× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.23× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.9M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $-44.2M | $1.1M |
| 自由现金流率自由现金流/营收 | -24.6% | 0.5% |
| 资本支出强度资本支出/营收 | 33.0% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 1.29× |
| 过去12个月自由现金流最近4个季度 | $-66.9M | $70.1M |
8季度趋势，按日历期对齐
经营现金流HTLDROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $14.9M | $46.9M | ||
| Q3 25 | $27.5M | $28.9M | ||
| Q2 25 | $21.0M | $13.7M | ||
| Q1 25 | $25.8M | $11.7M | ||
| Q4 24 | $37.8M | $33.7M | ||
| Q3 24 | $35.6M | $42.4M | ||
| Q2 24 | $40.0M | $22.9M |
自由现金流HTLDROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $-44.2M | $42.2M | ||
| Q3 25 | $-12.2M | $21.2M | ||
| Q2 25 | $-12.8M | $5.6M | ||
| Q1 25 | $2.3M | $2.1M | ||
| Q4 24 | $-45.5M | $18.3M | ||
| Q3 24 | $24.6M | $25.2M | ||
| Q2 24 | $29.4M | $8.8M |
自由现金流率HTLDROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | -24.6% | 20.9% | ||
| Q3 25 | -6.2% | 9.8% | ||
| Q2 25 | -6.1% | 2.8% | ||
| Q1 25 | 1.0% | 1.1% | ||
| Q4 24 | -18.8% | 9.5% | ||
| Q3 24 | 9.5% | 12.0% | ||
| Q2 24 | 10.7% | 4.1% |
资本支出强度HTLDROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 33.0% | 2.3% | ||
| Q3 25 | 20.2% | 3.6% | ||
| Q2 25 | 16.1% | 4.0% | ||
| Q1 25 | 10.7% | 5.0% | ||
| Q4 24 | 34.3% | 8.0% | ||
| Q3 24 | 4.2% | 8.2% | ||
| Q2 24 | 3.8% | 6.6% |
现金转化率HTLDROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
